COVID-19 and Industrial Injuries Disablement Benefit
Is prescription on the way for certain occupation types?
Industrial Injuries Disablement Benefit (IIDB) is a non-contributory and no-fault benefit paid consequent to an accident or prescribed disease which arose through work. Prescription will follow, if the Industrial Injuries Advisory Council considers the weight of epidemiological evidence to be a “risk of occupation”.
The Industrial Injuries Advisory Council (IIAC) in its report, “COVID-19 and Occupation”, published on 25 March 2021, stopped short of prescription for certain occupation types, despite the interim research finding that the disease had in some instances arisen “more likely than not” through occupational exposure – the so- called “doubling of risk”.
It did so by recognising that there was insufficient ‘good quality information’ to make definitive recommendations, acknowledging that its findings here may need to be adjusted for factors such as social deprivation. However, the authors saw a clear pathway for future prescription if further supporting evidence emerges.